Tralokinumab-ldrm is approved for the treatment of moderate-to-severe AD in adult and adolescent patients 12 years and older in the European Union, Canada, Great Britain, the United Arab Emirates, ...
Doctors should closely monitor patients with GPP for signs of PG, including a thorough assessment of painful ulcers of undetermined origin. A diagnosis of generalized pustular psoriasis (GPP) is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results